May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
Quality of Life in Patients With Glaucoma in Buenos Aires, Argentina
Author Affiliations & Notes
  • V. Krochik
    Consultorio Oftalmologico Dr. S. Lerner, Buenos Aires, Argentina
  • W. Loayza Gamboa
    Consultorio Oftalmologico Dr. S. Lerner, Buenos Aires, Argentina
  • A. Saenz Valiente
    Consultorio Oftalmologico Dr. S. Lerner, Buenos Aires, Argentina
  • F. Lerner
    Fundacion para el Estudio del Glaucoma, Buenos Aires, Argentina
    Ophthalmology, Univ Favaloro, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships  V. Krochik, None; W. Loayza Gamboa, None; A. Saenz Valiente, None; F. Lerner, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1585. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V. Krochik, W. Loayza Gamboa, A. Saenz Valiente, F. Lerner; Quality of Life in Patients With Glaucoma in Buenos Aires, Argentina. Invest. Ophthalmol. Vis. Sci. 2008;49(13):1585. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Different studies have addressed quality of life (QoL) in glaucoma. However, little has been published in terms of QoL in patients with glaucoma in Latin America. The purpose of this study was to evaluate the QoL in patients with mild, moderate, advanced, and very advanced glaucoma, using the 25-item National Eye Institute Visual Function Questionnaires (NEI-VFQ-25), in Buenos Aires, Argentina.

Methods: : This was a prospective study. A Spanish version of the NEI-VFQ-25 was developed with a previously standardized method. Patients, 18 years or older, with diagnosis of glaucoma were enrolled. All participants completed a demographic and the NEI-VFQ-25 questionnaires and underwent a complete ophthalmic examination. Optic nerve glaucomatous damage in the best eye was used to divide the patients into 4 categories: mild, moderate, advanced, and very advanced glaucoma. Corresponding perimetric damage was also evaluated in reliable visual fields. Vision-specific health related-quality of life was measured using 2 subscales (general vision and distance activities) and the composite score of 10 subscales (general vision, visual pain, near activities, distance activities, social functioning, mental health, role difficulties, dependency, color vision and peripheral vision) of the NEI-VFQ-25. Subscale scores have a minimum value of 0 indicating extreme disability and a maximum score of 100 indicating no disability. NEI-VFQ-25 subscales scores were compared between all categories of glaucoma damage with the Anova and Kruskal Wallis test (post test analysis).

Results: : Eighty one patients completed the questionnaires, 59.2% were female (n= 48) and 80% were 50 years or older (n= 65). Compared with mild and moderate glaucoma, the very advanced glaucoma group had significantly lower NEI-VFQ-25 subscale scores for distance activities, general vision and composite score (p < .05). The very advanced glaucoma group had lower values for the composite score than the advanced glaucoma group (p < .05).

Conclusions: : In our population, patients with very advanced glaucoma, had significantly lower NEI-VFQ-25 scores, when compared with the other groups. The NEI-VFQ-25 could be administered without difficulties in this population. Results of subscales may be used to address specific needs of these patients.

Keywords: quality of life • clinical (human) or epidemiologic studies: health care delivery/economics/manpower • visual fields 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.